As further evidenced by this settlement, the DOJ and SEC go on to sign the hazards linked to ill-defined swimming pools of reimbursable distributor bills (e.g. “marketing” or “administration” expenses), the usage of no cost samples, rebates, and other value concessions. The Alcon and Novartis AG DPAs undoubtedly are a reminder of the signif